Additional evidence for these rare subclones has been provided by the detection of low levels of KRAS mutations by sensitive PCR technology in patients with colorectal cancer who were found to be wild type for KRAS by standard methods [1]. The gene discussed is KRAS; the disease is colorectal cancer.